Cancer strategy 2023-2033: equalities (records) impact assessment

Equalities (records) impact assessment for the National Cancer Strategy for Scotland 2023-2033.


2. Framing

2.1 Results of framing exercise

Consultation on draft Strategy

Within Government

We have engaged internally with other policy teams. Included in these discussions were:

  • Chief Scientist Office
  • Chief Medical Officer
  • Clinical Priorities
  • Openness and Learning
  • Primary Care
  • Older people
  • Palliative Care
  • Pharmacy and Medicines
  • National strategies/specialist healthcare
  • Earlier Diagnosis
  • Diagnostics
  • Genomics
  • Mental Health
  • Health Inequalities
  • National Screening programmes
  • Population health teams – diet/obesity, alcohol, smoking etc.
  • Workforce (recruitment, modelling, care and wellbeing, pay, retirement)
  • Chief Nursing Officer/Allied Health Professionals
  • Person-centeredness and participation
  • Realistic Medicine
  • Infrastructure Spend
  • Health Technologies

We have also engaged with governance groups aligned to the current national cancer plan and other stakeholder bodies, including:

  • National Cancer Recovery Group
  • Cancer Data Programme Board
  • Detect Cancer Early Programme Board
  • Systemic Anti-Cancer Therapy Programme Board
  • Radiotherapy Programme Board
  • National Cancer Quality Steering Group
  • Scottish Primary Care Cancer Group
  • Endoscopy and Urology Diagnostic Group
  • Scottish Cancer Network
  • NHS Education for Scotland
  • Healthcare Improvement Scotland
  • Diagnostics in Scotland Steering Group

These groups are made up of leading clinicians and service managers from across NHS Scotland, as the main delivery body for the strategy and action plan.

In addition we have engaged directly with the following Health Boards and groups: National Services Division of NHS National Services Scotland, Public Health Scotland, Centre for Sustainable Delivery; and territorial Boards through the Scottish Association of Medical Directors, Board Chief Executives, Directors of Pharmacy, and Directors of Planning, as well as the Cancer Managers’ Forum and the Regional Cancer Networks.

Public Consultation

A public online consultation was open from 12 April to 7 June 2022. Views were sought on areas to prioritise in relation to cancer prevention, management and care: New cancer strategy: consultation - gov.scot (www.gov.scot)

257 responses were received - 156 responses were submitted by individuals and 101 responses submitted by organisations across various sectors.

The responses were independently analysed and the analysis was published on 17 November 2022: Cancer strategy: consultation analysis - gov.scot (www.gov.scot)

The responses, where consent was given, were also published on 17 November 2022:

Cancer strategy: draft vision, aims and priority areas - Scottish Government - Citizen Space (consult.gov.scot)

Business/Third Sector

We have consulted with the Scottish Cancer Coalition (SCC) and the Less Survivable Cancers Taskforce (LSCT) on the new Cancer Strategy. The SCC is a partnership of third sector organisations dedicated to improving cancer services and outcomes for patients in Scotland. The LSCT brings together six charities supporting patients who have these specific types of cancer.

We also consulted with a number of other third sector organisations not represented on the SCC, including:

  • CanRehab Trust
  • Marie Curie
  • CLL Support Association

2.2 Extent/Level of EQIA required

The policy may potentially impact on several of the protected characteristics to some extent so a full EQIA is required.

Contact

Email: cancerpolicyteam@gov.scot

Back to top